Living With Alpha-1

Zemaira CareZ offers the help and support you need at every step.

What is Alpha-1? A lifelong journey.

As a recently diagnosed Alpha, you may want to connect with other Alphas who truly understand what you may be going through. Your AlphaNet Coordinator is a fellow Alpha and a tremendously valuable resource. He or she knows firsthand what you may be experiencing and the questions you may have.* Of course, you can always talk to your doctor with questions you have about your diagnosis or treatment options.

As you begin your journey, we encourage you to gain a thorough understanding of Alpha-1. Watch this video to see how alpha-1 antitrypsin affects the lungs:

If you have been prescribed Zemaira, we strongly encourage you to join Zemaira CareZ, a network of people and services focused on providing the support you need as an Alpha, including help starting your Zemaira treatment, connecting with other Alphas, affording your treatment, and maintaining your health.

*AlphaNet Coordinators are neither healthcare professionals nor medical experts. Their assistance does not constitute professional guidance, therapy, or psychological counseling. Always contact your physician with medical questions. For their time and expenses, AlphaNet Coordinators are compensated by AlphaNet Inc., an independent, not-for-profit, 501(c)(3) health management organization.

Important Safety Information

Alpha1-Proteinase Inhibitor (Human), Zemaira® is indicated to raise the plasma level of alpha1-proteinase inhibitor (A1-PI) in patients with A1-PI deficiency and related emphysema. The effect of this raised level on the frequency of pulmonary exacerbations and the progression of emphysema have not been established in clinical trials.

Zemaira may not be suitable for everyone; for example, people with known hypersensitivity to components used to make Zemaira, those with a history of anaphylaxis or severe systemic response to A1-PI products, and those with certain IgA deficiencies. If you think any of these may apply to you, ask your doctor.

Early signs of hypersensitivity reactions to Zemaira include hives, rash, tightness of the chest, unusual breathing difficulty, wheezing, and feeling faint. Immediately discontinue use and consult with physician if such symptoms occur.

In clinical studies, the following adverse reactions were reported in at least 5% of subjects receiving Zemaira: headache, sinusitis, upper respiratory infection, bronchitis, fatigue, increased cough, fever, injection-site bleeding, nasal symptoms, sore throat, and swelled blood vessels.

Because Zemaira is made from human blood, the risk of transmitting infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Please see full prescribing information for Zemaira.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

CSL Behring

Zemaira is manufactured and distributed by CSL Behring LLC.
Zemaira® and CareZ® are registered trademarks of CSL Behring LLC.

© 2017 CSL Behring. The product information presented on this site is intended for US residents only.
ZMR14-04-0006d 12/2014